Please login to the form below

Not currently logged in
Email:
Password:

Kymab appoints its first chief medical officer

Dr Sonia Quaratino joins the firm from Novartis

Sonia QuaratinoKymab has appointed Dr Sonia Quaratino as its chief medical officer - a newly created role that will see her manage clinical development of the group’s expanding therapeutic antibody portfolio.

She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.

Dr Quaratino said: “Kymab’s emerging human antibody pipeline provides great potential to improve patient treatment options in our four main therapeutics areas of focus."

She previous served Novartis as its global clinical programme leader, transitional clinical oncology, with responsibility for the clinical development of proprietary therapeutic antibody programmes in immuno-oncology.

Prior to her time at Novartis, Quaratino worked for Merck Serono, where she was responsible for the clinical development of various immunomodulators.

Dr David Chiswell, CEO of Kymab, said: “I am delighted to welcome Sonia to Kymab. With her track demonstrated track record in clinical development and medical affairs, Sonia is a superb addition to Kymab’s management team as we prepare for our first clinical trials.

“Sonia’s deep understanding of the global environment in clinical research compliment those of Dr Arndt Schottelius, our new executive VP of R&D. These two key appointments add high calibre of depth and provide further validation to our burgeoning and advancing R&D pipeline.”

10th May 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....